BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 10506263)

  • 1. Melanocytic nevi in children treated with growth hormone.
    Wyatt D
    Pediatrics; 1999 Oct; 104(4 Pt 2):1045-50. PubMed ID: 10506263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sutton's nevus and growth hormone therapy.
    Bozzola E; Giacchero R; Barberi S; Borroni G
    Minerva Pediatr; 2004 Jun; 56(3):349-51. PubMed ID: 15252384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Halo nevi in Turner syndrome.
    Bello-Quintero CE; Gonzalez ME; Alvarez-Connelly E
    Pediatr Dermatol; 2010; 27(4):368-9. PubMed ID: 20653854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is high mole count a marker of more than melanoma risk? Eczema diagnosis is associated with melanocytic nevi in children.
    Dellavalle RP; Hester EJ; Stegner DL; Deas AM; Pacheco TR; Mokrohisky S; Morelli JG; Crane LA
    Arch Dermatol; 2004 May; 140(5):577-80. PubMed ID: 15148102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Height gains in response to growth hormone treatment to final height are similar in patients with SHOX deficiency and Turner syndrome.
    Blum WF; Cao D; Hesse V; Fricke-Otto S; Ross JL; Jones C; Quigley CA; Binder G
    Horm Res; 2009; 71(3):167-72. PubMed ID: 19188742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of growth hormone in non-growth hormone deficient children.
    Sood A; Menon PS
    Natl Med J India; 1998; 11(5):222-5. PubMed ID: 10997170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Growth hormone: who can benefit from it?].
    Schwarz HP
    Ther Umsch; 1995 Oct; 52(10):678-81. PubMed ID: 7482379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth hormone use in pediatric growth hormone deficiency and other pediatric growth disorders.
    Rosenfeld R; Allen DB; MacGillivray MH; Alter C; Saenger P; Anhalt H; Hintz R; Katz HP
    Am J Manag Care; 2000 Sep; 6(15 Suppl):S805-16. PubMed ID: 11184422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinician and payer issues in managing growth hormone deficiency.
    Owens GM
    Am J Manag Care; 2000 Sep; 6(15 Suppl):S839-52; quiz S853-5. PubMed ID: 11184425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin-like growth factor I and growth responses during the first year of growth hormone treatment in KIGS patients with idiopathic growth hormone deficiency, acquired growth hormone deficiency, turner syndrome and born small for gestational age.
    Cutfield WS; Lundgren F
    Horm Res; 2009 Jan; 71 Suppl 1():39-45. PubMed ID: 19153504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of genetic and environmental factors on melanocytic naevi: a lesson from Turner's syndrome.
    Zvulunov A; Wyatt DT; Laud PW; Esterly NB
    Br J Dermatol; 1998 Jun; 138(6):993-7. PubMed ID: 9747360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of growth hormone therapy in children after cardiac transplantation.
    Mital S; Andron A; Lamour JM; Hsu DT; Addonizio LJ; Softness B
    J Heart Lung Transplant; 2006 Jul; 25(7):772-7. PubMed ID: 16818119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of neonatal phototherapy on melanocytic nevus count in children.
    Matichard E; Le Hénanff A; Sanders A; Leguyadec J; Crickx B; Descamps V
    Arch Dermatol; 2006 Dec; 142(12):1599-604. PubMed ID: 17178986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fewer melanocytic nevi found in children with active atopic dermatitis than in children without dermatitis.
    Synnerstad I; Nilsson L; Fredrikson M; Rosdahl I
    Arch Dermatol; 2004 Dec; 140(12):1471-5. PubMed ID: 15611424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of human growth hormone therapy on melanocytic naevi.
    Bourguignon JP; Piérard GE; Ernould C; Heinrichs C; Craen M; Rochiccioli P; Arrese JE; Franchimont C
    Lancet; 1993 Jun; 341(8859):1505-6. PubMed ID: 8099381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human growth hormone treatment: Henry Ford Hospital experience 1964-1990.
    Leach DC
    Henry Ford Hosp Med J; 1991; 39(1):18-21. PubMed ID: 1856096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth hormone receptor exon 3 isoforms and their implication in growth disorders and treatment.
    Jorge AA; Arnhold IJ
    Horm Res; 2009 Apr; 71 Suppl 2():55-63. PubMed ID: 19407498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Naevocyte triggering by recombinant human growth hormone.
    Piérard GE; Piérard-Franchimont C; Nikkels A; Nikkels-Tassoudji N; Arrese JE; Bourguignon JP
    J Pathol; 1996 Sep; 180(1):74-9. PubMed ID: 8943819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prevalence of common acquired melanocytic nevi and the relationship with skin type characteristics and sun exposure among children in Lithuania.
    Valiukeviciene S; Miseviciene I; Gollnick H
    Arch Dermatol; 2005 May; 141(5):579-86. PubMed ID: 15897379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Number of acquired melanocytic nevi in patients with melanoma and control subjects in Japan: Nevus count is a significant risk factor for nonacral melanoma but not for acral melanoma.
    Rokuhara S; Saida T; Oguchi M; Matsumoto K; Murase S; Oguchi S
    J Am Acad Dermatol; 2004 May; 50(5):695-700. PubMed ID: 15097952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.